SHBG and How Much of Your Testosterone Is Free

SHBG: a plain-language definition of the protein

SHBG (sex hormone-binding globulin) is a glycoprotein produced primarily in the liver that binds tightly to sex hormones—especially testosterone and estradiol. When you test SHBG, you are measuring how much of this carrier protein is circulating and available to hold those hormones. High SHBG means more hormones are bound and unavailable to tissues; low SHBG means more hormones remain unbound and active. SHBG does not measure free hormone levels directly—those require separate assays or calculation.

How SHBG governs free hormone availability

Think of SHBG as the body's hormone accountant, controlling how much hormonal currency is available for use versus held in reserve. The liver increases SHBG output when it senses high estrogen or thyroid hormones, and reduces it when androgens rise, insulin spikes, or metabolic stress increases. This makes SHBG both a mirror and a messenger: it reflects the interplay between the endocrine system, liver function, and metabolic state.

Because the free fraction—not the total amount—determines hormonal impact, two people with identical total testosterone can have very different free testosterone depending on their SHBG levels. Low SHBG is associated with insulin resistance, fatty liver disease, and elevated cardiovascular risk. Higher, balanced SHBG is associated with lower risk of type 2 diabetes and longer lifespan in both men and women, making it a meaningful metabolic barometer beyond its role in hormone transport.

One of the most clinically important confounders of SHBG is oral estrogen use. Oral contraceptives and oral hormone replacement therapy dramatically raise SHBG through first-pass hepatic stimulation. This can suppress free testosterone even when total testosterone appears normal, producing symptoms of androgen deficiency—low libido, fatigue, mood changes—in women on the contraceptive pill or oral HRT. Transdermal estrogen bypasses the liver and does not have this effect. Interpreting SHBG without knowing a patient's route of estrogen administration can lead to significant misreading of results.

Reading your SHBG number in context

Normal ranges

Reference ranges vary between laboratories, so the values reported on your results sheet may differ slightly from those below. Typical SHBG levels are roughly 10–57 nmol/L for men and 18–144 nmol/L for women. What matters most is not the absolute number in isolation but how SHBG relates to free and total hormone levels—a dynamic relationship that reveals true hormonal status.

When levels run high

Elevated SHBG means the body is binding more hormones than it is releasing. Hyperthyroidism, low caloric intake, estrogen therapy, and pregnancy all stimulate hepatic SHBG synthesis. In men, SHBG tends to rise with age, and certain genetic variants in the SHBG gene produce persistently elevated levels regardless of lifestyle. The key clinical consequence is functional hormone deficiency: a man or woman can have normal total testosterone while free testosterone sits in a deficiency range, producing symptoms of low libido, fatigue, and difficulty building muscle that standard total-testosterone testing alone would miss.

When levels run low

Low SHBG keeps more hormones unbound and circulating, but this is not straightforwardly beneficial. Insulin resistance, obesity, hypothyroidism, high androgen exposure (including anabolic steroid use and androgen excess in conditions such as PCOS), liver dysfunction, and elevated triglycerides all suppress SHBG synthesis. In this context, low SHBG can signal underlying metabolic dysfunction rather than hormonal advantage—excess free androgen exposure and the metabolic conditions driving the suppression both carry independent health risks.

Factors that move SHBG between draws

Insulin and refined carbohydrate intake represent the most important modifiable driver of SHBG. Chronically elevated insulin suppresses hepatic SHBG production; improving insulin sensitivity through dietary changes—reducing added sugars and refined carbohydrates, increasing fiber and lean protein—tends to raise SHBG over weeks to months. Conversely, extreme caloric restriction can raise SHBG excessively, suppressing hormone availability even as metabolic markers improve elsewhere.

Thyroid status exerts a strong direct effect: hyperthyroidism raises SHBG and hypothyroidism lowers it. Because thyroid-driven SHBG shifts can mimic or mask metabolic or hormonal pathology, thyroid function should be assessed before attributing an unexplained SHBG change to diet or lifestyle alone.

The route of estrogen administration matters considerably. Oral estrogen—whether as a contraceptive pill or oral HRT—raises SHBG through first-pass liver stimulation. Transdermal estrogen does not. This distinction is clinically significant when evaluating free testosterone in women on hormone therapy.

Anabolic steroid use suppresses SHBG, sometimes dramatically, increasing free androgen exposure beyond what total testosterone measurements suggest. Weight loss generally raises SHBG by improving insulin sensitivity, though the magnitude depends on the degree of metabolic improvement achieved. Consistent aerobic and resistance exercise support SHBG stability indirectly through improvements in glucose control and liver health. Chronic stress and poor sleep lower SHBG over time by disrupting the hypothalamic–pituitary–gonadal axis and elevating cortisol. Moderate alcohol use has limited impact, but heavy drinking lowers SHBG through liver stress. Certain approaches to improving insulin sensitivity may influence SHBG over time; a clinician can advise on appropriate strategies.

Markers that read SHBG in context

• Total testosterone — total testosterone and SHBG together determine free testosterone; identical total testosterone values produce very different hormonal effects depending on SHBG level.
• Free testosterone — free testosterone is the biologically active fraction; high SHBG with normal total testosterone can suppress free testosterone into a functional deficiency range that only the free assay reveals.
• Estradiol — estradiol is the other major SHBG-bound sex hormone; SHBG shifts from thyroid changes, weight loss, or oral estrogen use alter estradiol bioavailability alongside testosterone.
• TSH — hyperthyroidism (low TSH) raises SHBG; hypothyroidism (high TSH) lowers it. TSH is often the primary driver of otherwise unexplained SHBG shifts and should be checked before attributing SHBG changes to diet or lifestyle.
• ALT — SHBG is produced by the liver; elevated ALT alongside low SHBG can indicate liver dysfunction as the driver, rather than metabolic syndrome, which changes the clinical pathway.

A realistic retest window for SHBG

SHBG responds relatively slowly to change. Meaningful shifts are seen in lifestyle and pharmacological trials within 8–12 weeks—the timeframe within which insulin sensitivity improvements, weight loss, thyroid correction, and discontinuation of oral estrogen all produce detectable SHBG movement. Retesting at 8–12 weeks after a confirmed intervention is a reasonable window to assess response.

For stable baseline tracking without an active intervention, annual monitoring is sufficient. To ensure comparability between draws, use the same laboratory and aim for a morning sample under consistent fasting conditions. Because SHBG alone cannot distinguish between causes, always interpret results alongside total and free testosterone—SHBG in isolation provides an incomplete picture.

When SHBG findings warrant a clinician conversation

SHBG results are most actionable when they diverge from what symptoms or other biomarkers would predict. A persistently elevated SHBG with symptoms of low hormone activity—fatigue, low libido, difficulty building muscle—warrants evaluation of thyroid function, caloric adequacy, and estrogen exposure route. A persistently low SHBG alongside elevated fasting glucose, triglycerides, or ALT points toward insulin resistance or liver fat accumulation as the underlying driver, and merits a broader metabolic workup rather than a narrow hormonal intervention.

Hormone therapy of any kind—oral contraceptives, HRT, or androgen therapy—can alter SHBG substantially, and levels should always be interpreted in that context. If SHBG is shifting in an unexpected direction between draws, checking TSH and liver enzymes before drawing conclusions about diet or lifestyle is a practical first step.

Testing SHBG transforms hormone interpretation from guesswork to precision. It explains why two people with the same total testosterone can feel completely different, and it surfaces metabolic and hepatic signals that a standard hormone panel alone would miss. Superpower's comprehensive biomarker panel includes SHBG, total and free testosterone, estradiol, and metabolic markers—giving a full picture of how hormones interact with liver and metabolic function. Learn more about the approach at our manifesto or visit superpower.com.